课题基金 / 基金详情

Preparation of carbon nanotube/alginate nanocomposite gel for tissue engineering

Preparation of carbon nanotube/alginate nanocomposite gel for tissue engineering
组织工程用碳纳米管/海藻酸盐纳米复合凝胶的制备
批准号:
17592057
负责人:
KAWAGUTCHI Minoru
金额:
$2.23万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2007

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
以海藻酸钠水凝胶为载体,制备了一种新型的含碳纳米管(CNTs)的支架材料,并对其力学性能和生物相容性进行了评价。采用酸处理法制备可溶性碳纳米管,并将其分散在海藻酸钠溶液中作为交联剂。之后,评价所得纳米复合凝胶(CNT-Alg凝胶)的机械性能(弹性变形)、盐水吸附、组织学反应和细胞活力。CNT-Alg凝胶比传统的海藻酸盐凝胶具有更快的凝胶化速度和更高的机械强度。冷冻干燥的CNT-Alg凝胶的盐吸附量与海藻酸钠凝胶的盐吸附量相当。在组织学评价和细胞活力测定方面,CNT-Alg凝胶表现出轻微的炎症反应和无细胞毒性。因此,这些结果表明,CNT-Alg凝胶可以作为一种支架材料在组织工程与碳纳米管的侧壁作为活性位点的化学功能化。
英文摘要
A novel scaffold material based on an alginate hydrogel which contained carbon nanotubes (CNTs) was prepared, and its mechanical property and biocompatibility evaluated. Soluble CNTs were prepared with acid treatment and dispersed in sodium alginate solution as a cross-linker. After which, the mechanical property (elastic deformation), saline sorption, histological reaction, and cell viability of the resultant nanocomposite gel (CNT-Alg gel) were evaluated. The CNT-Alg gel showed faster gelling and higher mechanical strength than the conventional alginate gel. Saline sorption amount of freeze-dried CNT-Alg gel was equal to that of the alginate gel. In terms of histological evaluation and cell viability assay,CNT-Alg gel exhibited a mild inflammatory response and non-cytotoxicity. These results thus suggested that CNT-Alg gel could be useful as a scaffold material in tissue engineering with the sidewalls of CNTs acting as active sites for chemical functionalization.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.4012/dmj.25.719
发表时间: 2006-12-01
期刊: DENTAL MATERIALS JOURNAL
影响因子: 2.5
作者: [Kawaguchi, Minoru, Fukushima, Tadao, Taniguchi, Kunihisa]
通讯作者: Taniguchi, Kunihisa
カーボンナノチューブ/アルギン酸ナノコンポジットによる再生医療用ゲルの創製
使用碳纳米管/藻酸盐纳米复合材料创建再生医学凝胶
DOI: --
发表时间: 2005
期刊:
影响因子: --
作者: [川口 稔, 他6名]
通讯作者: 他6名
国内基金
海外基金
NeuroRegen scaffold负载ChABC&Cetuximab移植对陈旧性脊髓损伤的修复作用及机制研究
  • 批准号:
    82372503
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    唐家广
  • 依托单位: